NCT07463976 2026-04-13
TITLE CLL
The Royal Wolverhampton Hospitals NHS Trust
Not yet recruiting
Clinical Trials
105 trialsNCT07503353 2026-03-31
A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Not yet recruiting
NCT06971848 2026-03-30
ETCABIO
University Hospital, Angers
Phase NA Not yet recruiting
NCT05636514 2026-03-18
CELESTIAL-MDS
Clinical Hub for Interventional Research (CHOIR)
Phase 1 Recruiting
NCT07147621 2026-03-06
HematoBrain
University Hospital, Angers
Recruiting
NCT07451743 2026-03-05
ACL ALL
ASL Lecce
Phase NA Not yet recruiting
NCT07367997 2026-01-26
CARE-RT
Jinnah Postgraduate Medical Centre
Phase NA Not yet recruiting
NCT07135466 2026-01-16
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Recruiting
NCT06782971 2025-12-08
COSMOS-Avatar
Clinical Hub for Interventional Research (CHOIR)
Recruiting
NCT07258043 2025-12-02
EPOCH
Hospital General de Mexico
Recruiting
NCT03136445 2025-10-28
TREATT
NHS Blood and Transplant
Phase 3 Completed
NCT06409767 2025-09-24
ALHERT
University Hospital, Angers
Phase NA Recruiting
NCT06026046 2025-09-19
EscrimHEMA
University Hospital, Angers
Phase NA Active not recruiting
NCT07014865 2025-08-29
MMYLIFE
Azienda USL Reggio Emilia - IRCCS
Recruiting
NCT07120607 2025-08-13
Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia
Anhui Provincial Hospital
Phase 1 Not yet recruiting
NCT07061145 2025-08-06
ED2024
Azienda USL Reggio Emilia - IRCCS
Recruiting
NCT07085559 2025-07-25
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Anhui Provincial Hospital
Phase EARLY_PHASE1 Recruiting
NCT03743480 2025-06-25
EPC-EMA1
Azienda USL Reggio Emilia - IRCCS
Phase NA Terminated
NCT06795815 2025-06-12
OHGW-ACP
Azienda USL Reggio Emilia - IRCCS
Phase NA Recruiting
NCT03403075 2025-06-11
ETAF
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT06793410 2025-06-05
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Vastra Gotaland Region
Phase 2 Recruiting
NCT04691284 2025-05-29
SCTMICROBIOM
National Cancer Institute, Slovakia
Phase NA Recruiting
NCT06961669 2025-05-29
ECAR01
Anhui Provincial Hospital
Phase NA Recruiting
NCT03746054 2025-03-17
PALERMO
University Hospital, Angers
Phase 3 Terminated
NCT06560879 2025-03-14
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia
National Institute of Pediatrics, Mexico
Phase 2 Enrolling by invitation
NCT05380570 2025-03-05
KRWS
Korea Institute of Radiological & Medical Sciences
Active not recruiting
NCT06299462 2025-02-25
PTCy and ATG for MSD and MUD Transplants
Instituto Nacional de Cancer, Brazil
Phase 1/2 Recruiting
NCT06758713 2025-01-06
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
The Third Affiliated Hospital of Southern Medical University
Phase 1 Recruiting
NCT05477589 2024-12-19
SCRIPT-AML
Vastra Gotaland Region
Phase 3 Recruiting
NCT05212103 2024-12-04
CANSI
Turku University Hospital
Enrolling by invitation
NCT05923541 2024-11-22
RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies
Henan Cancer Hospital
Phase EARLY_PHASE1 Completed
NCT05902845 2024-11-21
RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL
Anhui Provincial Hospital
Phase EARLY_PHASE1 Completed
NCT04637113 2024-11-07
SHACK
KK Women's and Children's Hospital
Completed
NCT02416388 2024-08-07
BIG-1
University Hospital, Angers
Phase 2/3 Recruiting
NCT04311216 2024-07-22
Shoulder Instability in Children: Muscle Activity and Movement
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
Completed
NCT06480630 2024-06-28
Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases
Anhui Provincial Hospital
Phase 2 Not yet recruiting
NCT03493646 2024-05-28
Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
Kirby Institute
Phase 2 Completed
NCT05536154 2024-03-19
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase NA Unknown
NCT06277011 2024-02-26
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
Anhui Provincial Hospital
Phase EARLY_PHASE1 Unknown
NCT06262789 2024-02-16
RAT-HEMATO
University Hospital, Angers
Phase NA Not yet recruiting
NCT06256627 2024-02-13
The Maintenance Treatment of "ITIVA" in AML Patients
Henan Cancer Hospital
Phase NA Recruiting
NCT04257175 2023-11-28
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression
Sheba Medical Center
Phase 2/3 Unknown
NCT04989335 2023-11-28
Bisantrene Combination for Resistant AML
Sheba Medical Center
Phase 2 Unknown
NCT06105658 2023-10-30
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
Anhui Provincial Hospital
Phase 2 Unknown
NCT05510089 2023-10-10
Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase NA Unknown
NCT05950204 2023-07-18
Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia.
Coordinación de Investigación en Salud, Mexico
Phase NA Unknown
NCT05429905 2023-03-09
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
KK Women's and Children's Hospital
Phase 1/2 Unknown
NCT05648019 2023-03-09
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
KK Women's and Children's Hospital
Phase 2 Recruiting
NCT05528887 2022-09-06
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase 1 Recruiting
NCT04271215 2022-07-20
Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia
Coordinación de Investigación en Salud, Mexico
Unknown